News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Wee Joo Chng: Resistance to immunomodulatory drugs in multiple myeloma – the cereblon pathway and beyond
NUS Yong Loo Lin School of Medicine/LinkedIn
Jun 24, 2025, 09:42

Wee Joo Chng: Resistance to immunomodulatory drugs in multiple myeloma – the cereblon pathway and beyond

Wee Joo Chng, Professor in Medical Oncology at the National University of Singapore, shared a post on LinkedIn:

“Happy to share a paper from my group that was recently published in Hematologica. In this paper, we summarises the current knowledge on the mechanisms of resistance to immunomodulatory drugs In myeloma. These drugs are mainstay in myeloma treatment. Resistance is an important mechanism for treatment failure, so understanding the biology and rationally designing strategies to overcome resistance is important.”

Title: Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond

Authors: Phaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, Sarah Gooding, Wee Joo Chng

Read the Full Article.

Wee Joo Chng

cancer Constantine Mitsiades Immunomodulatory drugs multiple myeloma Mun Yee Koh Myeloma OncoDaily Oncology Phaik Ju Teoh Sarah Gooding Wee Joo Chng
Special Coverage
Oncolibrary
Jul 1, 2025, 12:44
MASCC 2025 Highlights: StrataXRT Prevents Severe Radiation Dermatitis in Large-Breasted Women Undergoing Prone Breast Radiotherapy
Blog
Jul 1, 2025, 10:46
INTERACT-EUROPE 100 Has Launched a New Round of Recruitment - European Cancer Organisation
Societies
Jul 1, 2025, 10:32
25 Posts Not To Miss From MASCC 2025
Blog
Jul 1, 2025, 10:30
Alina Comanescu: Urgent Call to Action - Don't Let Cancer Slip Off the EU Agenda
Blog
Jul 1, 2025, 10:16
Survivor Cindy Pursues Nursing in Ghana Fifteen Years After Kidney Cancer Diagnosis - World Child Cancer
Blog
Jul 1, 2025, 10:07
Treatment Optimisation: Making Cancer Treatment Accessible and Sustainable in Europe - EORTC
Blog
Jul 1, 2025, 09:57
Gevorg Tamamyan: To Me, MD Anderson Has Always Meant Dr. Kantarjian
Career
Jul 1, 2025, 09:56
Sidney Chahonyo is Breaking Barriers as the First Survivor on the Board of Childhood Cancer International
Blog
Jul 1, 2025, 09:34
Jasmine Kamboj: Congratulating the New Co-Leads of the Community of Practice Policy
Dialogues
Jul 1, 2025, 09:27
Top Biotechs at ASCO: Ruthie Davi on AI and Data Insights in Platinum-Resistant Ovarian Cancer
Blog
Jul 1, 2025, 09:25
Alexandre Chan's Final Reflection on MASCC 2025
Dialogues
Jul 1, 2025, 09:21
Women Leaders in Oncology: Nina Mojas on GSK’s Oncology Growth and Innovation Strategy